<DOC>
	<DOCNO>NCT00174239</DOCNO>
	<brief_summary>The study assess relative benefit cabergoline v carbidopa/levodopa therapy treat nighttime problem Parkinson Disease .</brief_summary>
	<brief_title>Study Of Cabaser Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson 's Disease .</brief_title>
	<detailed_description>The trial terminate prematurely June 26 , 2005 due inability re-supply study drug plan number subject . There safety efficacy concern regard study decision terminate trial .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<criteria>Idiopathic Parkinson Disease Must experience sleep akinesia Current treatment dopamine agonists Nocturnal hallucination Dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2007</verification_date>
</DOC>